Description: HCP's, find important information about LUCENTIS® (ranibizumab injection) a treatment option for patients with wet AMD, DR & DME, mCNV, and RVO. See full safety for more information.
Learn more about LUCENTIS’ strength in vision and support across 5 retinal indications below.
LUCENTIS ® (ranibizumab injection) is indicated for the treatment of patients with:
LUCENTIS is contraindicated in patients with ocular or periocular infections or known hypersensitivity to ranibizumab or any of the excipients in LUCENTIS. Hypersensitivity reactions may manifest as severe intraocular inflammation.